POINT Investigators

Please note: The NINDS has discontinued further randomization into the POINT Trial based on the recommendation of the Data and Safety Monitoring Board (DSMB). For more information, please visit ClinicalTrials.gov.

Click here for POINT Training and Resources including FAQs, Protocol, and POINT Toolbox.
The POINT 24-Hour Hotline is -POINT ().